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PSORS1: Linking Genetics and 
Immunology
James T. Elder1
Previous studies have localized the psoriasis susceptibility 1 (PSORS1) locus to 
the proximal major histocompatibility complex class I region, but approximately 
a dozen genes in the candidate region have thus far been genetically insepa-
rable. According to a team of researchers in the United States and Germany, the 
primary genetic association has now been worked out, implicating HLA-Cw6 
“after all.” The results integrate genetics and immunology, further reinforcing 
our emerging understanding of psoriasis.
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Psoriasis is an inflammatory and 
hyperplastic skin disease accom-
panied by arthritis in approximate-
ly one-fourth of patients. Multiple 
lines of evidence implicate a state of 
local immunologic activation in pso-
riasis and suggest that this state is 
maintained by T-cell responses to self-
antigens. It has also long been appreci-
ated that psoriasis has a genetic basis, 
albeit a complex one that involves the 
interaction of multiple genes and envi-
ronmental factors. In a paper published 
in the May issue of the American Journal 
of Human Genetics (Nair et al., 2006), 
we bring together these two facets of 
psoriasis with the identification of HLA-
Cw6 as the disease allele at the psoriasis 
susceptibility 1 (PSORS1) locus.
On the basis of a decade of genome-
wide linkage scans, PSORS1 is the 
strongest susceptibility locus detect-
able by family-based linkage studies, 
accounting for one-third to one-half 
of the genetic liability to psoriasis. 
Although associations between HLA-
Cw6 and psoriasis have been known 
for over 25 years, nailing down HLA-
Cw6 as “the” PSORS1 gene proved to 
be a challenge. As the sequence of the 
human genome has been determined, 
at least ten other genes were mapped 
to the “neighborhood” just telomeric 
to HLA-C (Figure 1). As the variation 
in these genes was defined, it became 
clear that several of them also showed 
strong associations with psoriasis, 
often of a magnitude comparable to 
that shown by HLA-C. Several of these 
genes, including CDSN, HCR, and 
PSORS1C3, are expressed in skin cells 
and made very plausible candidates 
for the PSORS1 gene. We now know 
that the existence of multiple associ-
ated genes is a consequence of link-
age disequilibrium — the tendency for 
particular alleles at two or more loci 
to be inherited together more often 
than would be predicted by chance. 
The International HapMap Project has 
now characterized patterns of linkage 
disequilibrium across the genome and 
found that the major histocompatibility 
complex class I subregion containing 
HLA-C and its ten neighbors is char-
acterized by a recombination rate 2.3 
times lower than the genomic average 
(Walsh et al., 2003). Thus the genes in 
this region are all associated with pso-
riasis because they are all in linkage 
disequilibrium with each other.
In order to identify PSORS1, we car-
ried out a three-pronged attack on this 
problem. First, we identified over 60 
ancestral haplotypes across the major 
histocompatibility complex and then 
found the shortest region common to 
different risk haplotypes. Ultimately, this 
proved to be a 300-kb region extending 
telomerically from (but not including) 
HLA-B, including the HLA-C, HCG27, 
PSORS1C3, OTF3, TCF19, SPR1, SEEK1, 
HCR, STG, and HCG22 genes (Figure 1). 
Second, we determined the sequence of 
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this 300-kb interval for seven different 
chromosomes, two of which definitely 
conferred risk, and five of which defi-
nitely did not. This was a considerable 
task, as each chromosome had to be 
reconstructed from cloned large-insert 
genomic DNA, recloned into smaller 
plasmids for sequencing, and then com-
putationally reassembled into complete 
sequence. Once this was accomplished, 
we compared the sequences, looking 
for variants unique to the risk chromo-
somes. Here things became tricky, as 
nature often deals out variation more 
than one mutation at a time. This is par-
ticularly true of the HLA genes them-
selves, in which multiple variations 
have accumulated in the peptide-bind-
ing grooves essential for peptide anti-
gen presentation. Because of this, it was 
necessary to consider variations two, 
three, four, and more at a time, mean-
ing that there were literally millions 
of combinations that could be unique 
to the risk chromosomes. This meant 
that we could not analyze all possible 
combinations, but only those affecting 
spliced mRNA or translated protein. Our 
analysis revealed that SPR1 and SEEK1 
have mRNA alleles unique to risk, but 
only HLA-C and CDSN have protein 
alleles unique to risk. In the second 
prong of our approach, we determined 
the variation of HLA-C and CDSN in 
our entire sample, rather than just in the 
sequenced chromosomes. This revealed 
that HLA-Cw6 and a previously known 
allele called CDSN*TTC were both very 
strongly associated with psoriasis. But 
this much had already been known — 
how could we proceed further?
In the third prong, the HLA-C and 
CDSN variants were “plugged in” to 
our preexisting knowledge of ances-
tral major histocompatibility complex 
haplotypes by application of haplotype 
cluster analysis. Once this was done, 
we identified 76 genetically indepen-
dent individuals who carried frag-
ments of the ancestral risk chromosome 
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bearing either HLA-Cw6 or CDSN*TTC, 
but not both. It turned out that recom-
binant haplotypes retaining HLA-Cw6 
but lacking CDSN*TTC were significant-
ly associated with psoriasis, whereas 
recombinants retaining CDSN*TTC but 
lacking HLA-Cw6 were not associated, 
despite good statistical power. Once 
these critical individuals were identified, 
their families were typed for additional 
markers between HLA-C and CDSN, 
allowing us to further map the break-
points of the informative recombinant 
ancestral chromosomes. By grouping 
recombinants with similar breakpoints, 
we were able to confidently exclude the 
telomeric 25% of the 300-kb candidate 
interval. Furthermore, analysis of rare 
recombinants would allow us to exclude 
all genes except HLA-C and HCG27, 
but our sample size was too small to 
be definitive. It is important to resolve 
these remaining issues, because our 
analysis cannot rule out combinations of 
variations that might influence promoter 
regions or regulatory RNAs. Fortunately, 
this can readily be accomplished with 
use of a large ongoing collaborative 
effort to map PSORS1, sponsored by 
the National Psoriasis Foundation. Also, 
because all the markers used to carry 
out our analysis are published, any 
group can readily confirm and extend 
our results.
How is HLA-Cw6 involved in pso-
riasis pathophysiology? At this point, the 
leading hypothesis involves its antigen-
presenting capacity. Guttate psoriasis is 
strongly associated with HLA-Cw6 and 
is triggered by streptococcal pharyngi-
tis. It is interesting that the tonsils are the 
only lymphoid organ directly covered 
by stratified squamous epithelium, and 
that the T cells educated in the tonsil 
are almost exclusively of the skin-hom-
ing variety. It is possible that appropriate 
responses to streptococci in the tonsils 
could spread to involve self-antigens 
overexpressed in the skin in the context 
of psoriasis, such as keratin 17. There is 
published evidence that skin-homing, 
CD8 T cells of HLA-Cw6-positive psori-
atics respond more strongly to peptides 
common to both keratin 17 and strep-
tococcus than do CD8 T cells of HLA-
Cw6-negative psoriatics (Johnston et 
al., 2004). Another possible function of 
HLA-Cw6 is regulation of natural killer 
cells, via killer Ig-like receptors. Killer 
Ig-like receptors have been associated 
with psoriasis and psoriatic arthritis 
(Luszczek et al., 2004; Nelson et al., 
2004), but many other HLA-C alleles 
share with HLA-Cw6 the “group 2” 
lysine motif at position 80 thought to be 
critical for natural-killer-cell regulation. 
By ana logy with HLA-B27 in ankylos-
ing spondylitis (Reveille and Arnett, 
2005), the HLA-Cw6 protein might also 
misfold, form a homodimer, or behave 
abnormally in some other aspect of its 
intracellular trafficking. To date, there 
are no convincing studies of HLA-Cw6 
protein expression in psoriasis.
By analogy with recent progress impli-
cating the filaggrin (FLG) gene in ich-
thyosis vulgaris (Smith et al., 2006) and 
atopic dermatitis (Palmer et al., 2006), 
it could be argued that we have simply 
discovered the obvious. However, we 
very strongly feel that this is critical new 
knowledge that our immunologist col-
leagues can “take to the bank” as they 
continue to elucidate the immunopatho-
genesis of psoriasis. At the same time, 
this new information provides a means 
of stratifying further studies of genetic 
variation and of gene expression in pso-
riasis, allowing us to seek out the inter-
actions of other genes with PSORS1. 
Ultimately, progress in both immuno-
logy and genetics will pay off for our 
patients, in terms of safer, more effective 
medications, and perhaps even a cure.
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Figure 1. PSORS1 candidate interval. Known genes are shown below the coordinate axis, and key 
microsatellite markers are shown above it. The candidate interval was originally defined as 59.7-kb-long 
risk haplotype 1 (RH1) (Nair et al., 2000) and was later expanded to 300 kb on the basis of sequencing 
of the regions immediately flanking RH1 and after incorporation of results reassessing the association of 
an HLA-Cw8-B65 haplotype with psoriasis (Elder et al., 2005).
